The key trends observed in the acne treatment markets are gradual shift of patients towards combination products such as Ziana (clindamycin phosphate and tretinoin) and Duac (clindamycin phosphate and benzoyl peroxide), increase in safety and efficiency concerns about anti-acne products e.g. in January 2013 French and Netherland health authorities suspended Diane 35 one of the Bayer’s product due to concerns related with its property to increase blood clots.
The therapeutic market of acne treatment is currently dominated by generic products and branded products generally account for the small portion of the overall market. The major slowdown in the anti-acne drug market was observed due to entry of generics and increasing acceptance of alternative anti-acne treatments such as UV/blue light therapy and photodynamic therapy. The major events which will aid the growth of acne treatment market were patent expiration of Epiduo in late 2011 and Duac will expire in 2014.
North America accounts for the largest market share in acne treatment because of according to American Academy of Dermatology; Acne is the most common skin disorder in the United States, affecting 40 million to 50 million Americans. It was also observed that mid-teens, more than 40 percent of adolescents have acne or acne scarring, which requires treatment by a dermatologist. In year 2008, the total direct cost associated with the treatment of acne exceeded $2.2 billion, including substantial costs for prescription and over-the-counter products.
Request for Table of Content@ http://www.persistencemarketresearch.com/toc/5279
Europe is observed to be the second largest market for acne treatment and non-invasive cosmetic treatments are observed to be the method of choice by most of the adult patients suffering with acne. Asia-Pacific and Rest of the World are observed to be the mature markets in case of drugs and other products while cosmetic treatments are on a verge of exponential growth especially in the economies such as China, South Korea, India, Japan, Brazil and Mexico.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353